MANZAR Y RAJPUT
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- HOWELL, MI
- NPI
- 1851358527
- Received
- $612,193 in 1,048 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 394 | $264,517 |
| 2024 | General payment | 335 | $214,160 |
| 2023 | General payment | 181 | $94,046 |
| 2022 | General payment | 66 | $19,396 |
| 2021 | General payment | 26 | $4,927 |
| 2020 | General payment | 28 | $6,276 |
| 2019 | General payment | 18 | $8,867 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ABBVIE INC. | 298 | $186,162 | 2021–2025 |
| Axsome Therapeutics, Inc. | 183 | $140,246 | 2023–2025 |
| Teva Pharmaceuticals USA, Inc. | 142 | $123,433 | 2022–2025 |
| E.R. Squibb & Sons, L.L.C. | 117 | $73,269 | 2024–2025 |
| Alkermes, Inc. | 102 | $51,158 | 2022–2025 |
| IDORSIA PHARMACEUTICALS US INC | 41 | $19,616 | 2022–2023 |
| Allergan, Inc. | 34 | $14,914 | 2019–2020 |
| Otsuka America Pharmaceutical, Inc. | 25 | $1,203 | 2020–2025 |
| Lundbeck LLC | 27 | $526 | 2020–2025 |
| Neurocrine BioSciences, Inc. | 23 | $517 | 2022–2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $275 | 2019–2025 |
| Janssen Pharmaceuticals, Inc | 10 | $209 | 2022–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $158 | 2020–2024 |
| Supernus Pharmaceuticals, Inc. | 6 | $148 | 2023–2025 |
| Brainsway USA INC | 1 | $98 | 2024 |
| Sunovion Pharmaceuticals Inc. | 6 | $59 | 2019–2021 |
| Corium, LLC | 4 | $58 | 2023 |
| Indivior Inc. | 2 | $44 | 2022–2024 |
| Validus Pharmaceuticals LLC | 2 | $38 | 2023–2025 |
| Bausch Health US, LLC | 2 | $35 | 2022 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 | 2024 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 169 | $405,234 |
| Consulting Fee | 31 | $88,646 |
| Honoraria | 22 | $64,450 |
| Travel and Lodging | 287 | $29,735 |
| Food and Beverage | 535 | $23,916 |
| Education | 4 | $210 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | Takeda Pharmaceuticals U.S.A., Inc. | $28 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-12-19 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-18 | Axsome Therapeutics, Inc. | $2,475 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-18 | Axsome Therapeutics, Inc. | $93 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-18 | Axsome Therapeutics, Inc. | $22 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-18 | Axsome Therapeutics, Inc. | $10 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-16 | Axsome Therapeutics, Inc. | $2,475 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-16 | Axsome Therapeutics, Inc. | $120 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-16 | Axsome Therapeutics, Inc. | $21 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-16 | Axsome Therapeutics, Inc. | $10 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-15 | E.R. Squibb & Sons, L.L.C. | $105 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-15 | Otsuka America Pharmaceutical, Inc. | $32 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-12-15 | Neurocrine BioSciences, Inc. | $12 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-12-11 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-04 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-04 | E.R. Squibb & Sons, L.L.C. | $119 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-04 | E.R. Squibb & Sons, L.L.C. | $70 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-04 | E.R. Squibb & Sons, L.L.C. | $10 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-03 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-12-01 | Teva Pharmaceuticals USA, Inc. | $2,995 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-12-01 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-01 | Teva Pharmaceuticals USA, Inc. | $42 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-11-30 | Teva Pharmaceuticals USA, Inc. | $529 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-11-25 | E.R. Squibb & Sons, L.L.C. | $6,555 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-25 | E.R. Squibb & Sons, L.L.C. | $121 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-24 | Lundbeck LLC | $25 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-20 | E.R. Squibb & Sons, L.L.C. | $2,760 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-20 | E.R. Squibb & Sons, L.L.C. | $196 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-20 | E.R. Squibb & Sons, L.L.C. | $45 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-20 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-19 | Axsome Therapeutics, Inc. | $2,475 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-19 | Axsome Therapeutics, Inc. | $121 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-19 | Axsome Therapeutics, Inc. | $63 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-19 | Axsome Therapeutics, Inc. | $10 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-18 | Axsome Therapeutics, Inc. | $2,475 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-18 | Axsome Therapeutics, Inc. | $124 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-18 | Axsome Therapeutics, Inc. | $50 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-18 | Neurocrine BioSciences, Inc. | $21 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-18 | Axsome Therapeutics, Inc. | $10 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-17 | Axsome Therapeutics, Inc. | $2,475 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-17 | Axsome Therapeutics, Inc. | $125 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-17 | Axsome Therapeutics, Inc. | $49 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-17 | Axsome Therapeutics, Inc. | $10 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-13 | E.R. Squibb & Sons, L.L.C. | $3,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-13 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-13 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-13 | E.R. Squibb & Sons, L.L.C. | $121 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-12 | E.R. Squibb & Sons, L.L.C. | $149 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-12 | Alkermes, Inc. | $102 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-11-12 | ABBVIE INC. | $70 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-12 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-12 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-12 | E.R. Squibb & Sons, L.L.C. | $7 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-11 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-10 | E.R. Squibb & Sons, L.L.C. | $110 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-10 | Neurocrine BioSciences, Inc. | $23 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-06 | Teva Pharmaceuticals USA, Inc. | $4,493 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-11-06 | Teva Pharmaceuticals USA, Inc. | $244 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-11-06 | Teva Pharmaceuticals USA, Inc. | $19 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-11-06 | Teva Pharmaceuticals USA, Inc. | $2 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-11-05 | Axsome Therapeutics, Inc. | $2,475 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-05 | Axsome Therapeutics, Inc. | $121 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-05 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-05 | Axsome Therapeutics, Inc. | $21 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-05 | Axsome Therapeutics, Inc. | $10 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-11-04 | E.R. Squibb & Sons, L.L.C. | $142 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-04 | E.R. Squibb & Sons, L.L.C. | $119 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-04 | Teva Pharmaceuticals USA, Inc. | $11 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-10-30 | ABBVIE INC. | $70 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-30 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-29 | Teva Pharmaceuticals USA, Inc. | $3,894 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-10-29 | ABBVIE INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-29 | Teva Pharmaceuticals USA, Inc. | $168 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-10-29 | Teva Pharmaceuticals USA, Inc. | $120 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-10-29 | Teva Pharmaceuticals USA, Inc. | $120 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-10-29 | Neurocrine BioSciences, Inc. | $28 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-28 | E.R. Squibb & Sons, L.L.C. | $300 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-28 | E.R. Squibb & Sons, L.L.C. | $124 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-27 | E.R. Squibb & Sons, L.L.C. | $130 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-27 | Lundbeck LLC | $26 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-23 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-23 | Janssen Pharmaceuticals, Inc | $35 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-10-23 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-10-22 | Janssen Pharmaceuticals, Inc | $22 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-10-21 | Alkermes, Inc. | $22 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-10-16 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-16 | ABBVIE INC. | $35 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-16 | ABBVIE INC. | $10 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-15 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-15 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-14 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-14 | ABBVIE INC. | $386 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-14 | ABBVIE INC. | $175 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-14 | ABBVIE INC. | $115 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-14 | ABBVIE INC. | $45 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-13 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-10 | E.R. Squibb & Sons, L.L.C. | $35 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-10 | E.R. Squibb & Sons, L.L.C. | $10 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-10 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $574 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $326 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $134 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $64 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $51 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $49 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-08 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-07 | Axsome Therapeutics, Inc. | $32 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-02 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-02 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-01 | Teva Pharmaceuticals USA, Inc. | $4,493 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-10-01 | Teva Pharmaceuticals USA, Inc. | $210 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-10-01 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-30 | E.R. Squibb & Sons, L.L.C. | $198 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-30 | E.R. Squibb & Sons, L.L.C. | $55 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-29 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-25 | E.R. Squibb & Sons, L.L.C. | $125 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-25 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-09-22 | Lundbeck LLC | $34 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-20 | E.R. Squibb & Sons, L.L.C. | $73 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-19 | ABBVIE INC. | $137 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-19 | Teva Pharmaceuticals USA, Inc. | $119 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-09-17 | Neurocrine BioSciences, Inc. | $28 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-16 | Alkermes, Inc. | $3,060 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-09-15 | E.R. Squibb & Sons, L.L.C. | $121 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-15 | Neurocrine BioSciences, Inc. | $25 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-11 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-10 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-25 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-20 | Teva Pharmaceuticals USA, Inc. | $4,493 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-08-20 | Axsome Therapeutics, Inc. | $2,475 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-20 | Teva Pharmaceuticals USA, Inc. | $182 | Travel and Lodging | Cash or cash equivalent | UZEDY Drug, Neurology | 2025 | |
| 2025-08-20 | Axsome Therapeutics, Inc. | $124 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-20 | Axsome Therapeutics, Inc. | $70 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-20 | Alkermes, Inc. | $70 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-08-20 | Teva Pharmaceuticals USA, Inc. | $29 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-08-20 | Axsome Therapeutics, Inc. | $10 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-18 | Lundbeck LLC | $28 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-18 | Lundbeck LLC | $1 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-16 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-15 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-15 | ABBVIE INC. | $232 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-15 | ABBVIE INC. | $114 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-15 | ABBVIE INC. | $84 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-15 | ABBVIE INC. | $10 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-14 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-14 | E.R. Squibb & Sons, L.L.C. | $124 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-13 | Alkermes, Inc. | $960 | Consulting Fee | Cash or cash equivalent | LYBALVI Drug, CNS | 2025 | |
| 2025-08-13 | Alkermes, Inc. | $46 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2025 | |
| 2025-08-13 | Supernus Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-08-12 | Axsome Therapeutics, Inc. | $2,475 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-12 | Axsome Therapeutics, Inc. | $120 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-12 | Axsome Therapeutics, Inc. | $22 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-11 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-08 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-08 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-08 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-08 | E.R. Squibb & Sons, L.L.C. | $35 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-06 | ABBVIE INC. | $35 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-06 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-04 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-01 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-01 | ABBVIE INC. | $70 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-01 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-01 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-31 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-29 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-28 | Neurocrine BioSciences, Inc. | $27 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-24 | ABBVIE INC. | $35 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-24 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-23 | Axsome Therapeutics, Inc. | $2,475 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-23 | Axsome Therapeutics, Inc. | $120 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-23 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-23 | Axsome Therapeutics, Inc. | $21 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-22 | ABBVIE INC. | $70 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-22 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-21 | ABBVIE INC. | $35 | Travel and Lodging | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-21 | Lundbeck LLC | $25 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-17 | E.R. Squibb & Sons, L.L.C. | $4 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-16 | E.R. Squibb & Sons, L.L.C. | $135 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-16 | Validus Pharmaceuticals LLC | $23 | Food and Beverage | Cash or cash equivalent | RALDESY Drug, CNS | 2025 | |
| 2025-07-14 | Neurocrine BioSciences, Inc. | $27 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-09 | Axsome Therapeutics, Inc. | $1,650 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-09 | Axsome Therapeutics, Inc. | $70 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-09 | Axsome Therapeutics, Inc. | $23 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-08 | Axsome Therapeutics, Inc. | $3,575 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-08 | Axsome Therapeutics, Inc. | $185 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-08 | Axsome Therapeutics, Inc. | $124 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-08 | Axsome Therapeutics, Inc. | $105 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-07 | E.R. Squibb & Sons, L.L.C. | $70 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-07 | Axsome Therapeutics, Inc. | $22 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-02 | Axsome Therapeutics, Inc. | $2,475 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-02 | E.R. Squibb & Sons, L.L.C. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-02 | Axsome Therapeutics, Inc. | $124 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-02 | Axsome Therapeutics, Inc. | $35 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-30 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-26 | Axsome Therapeutics, Inc. | $3,575 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-26 | Axsome Therapeutics, Inc. | $90 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-06-26 | Axsome Therapeutics, Inc. | $72 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 |
The latest 200 records of 1,048.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Howell, MI, county Livingston County, MI, state Michigan; placed by its city name.
| Measure | Place (city or town) Howell, MI | County Livingston County, MI | State Michigan |
|---|---|---|---|
| Population B01003 | 10,021 | 195,833 | 10,077,761 |
| Population, 2020 census P1 | 10,068 | 193,866 | 10,077,331 |
| Median age B01002 | 40.8 | 43.9 | 40.2 |
| Under 18 B01001 | 15.9% | 20.3% | 21.2% |
| 65 and over B01001 | 19.2% | 19.7% | 18.6% |
| Households B11001 | 4,862 | 76,445 | 4,076,369 |
| Foreign born B05002 | 4.3% | 3.0% | 7.2% |
| Median household income B19013 | $60,449 | $103,039 | $72,875 |
| Median family income B19113 | $93,886 | $121,654 | $93,357 |
| Per capita income B19301 | $44,479 | $51,721 | $40,735 |
| Poverty rate B17001 | 7.7% | 5.1% | 13.2% |
| Unemployment rate B23025 | 3.2% | 3.4% | 5.7% |
| Civilian labor force B23025 | 5,702 | 102,834 | 5,018,449 |
| Mean commute (minutes) B08013 | 29.9 | 30.6 | 24.2 |
| Bachelor's degree or higher B15003 | 31.2% | 40.2% | 32.4% |
| Housing units B25001 | 5,146 | 80,367 | 4,622,236 |
| Owner-occupied B25003 | 53.9% | 86.9% | 73.2% |
| Renters B25003 | 46.1% | 13.1% | 26.8% |
| Median home value B25077 | $265,600 | $356,800 | $231,600 |
| Median gross rent B25064 | $1,177 | $1,287 | $1,129 |
| White, not Hispanic B03002 | 86.5% | 92.4% | 72.4% |
| Black B03002 | 1.3% | 0.6% | 13.1% |
| Hispanic or Latino B03002 | 8.6% | 3.0% | 5.9% |
| Asian B03002 | 0.8% | 0.9% | 3.4% |
| American Indian and Alaska Native B03002 | 0.2% | 0.2% | 0.3% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Howell, MI.
Comments